Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

Presentation TCT 2025

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

Presenter: Jingpu Wang

October 28, 2025

Presentation TCT 2025

TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials

Presenter: Prakash Upreti

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Aditya Desai

October 28, 2025

Presentation TCT 2025

TCT 568: Safety and Long-Term Efficacy of First Septal Coil Embolization in Patients with Hypertrophic Obstructive Cardiomyopathy

Presenter: Melissa McCormack

October 28, 2025

Presentation TCT 2025

TCT 1270: Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy

Presenter: Prakash Upreti

October 27, 2025

Presentation TCT 2025

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

Presenter: Usman Akbar

October 27, 2025

Presentation TCT 2025

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

Presenter: Luca Arzuffi

October 27, 2025

Presentation TCT 2025

TCT 556: Fibromuscular Subaortic Stenosis Misdiagnosed as Dynamic Left Ventricular Outflow Obstruction due to Hypertrophic Cardiomyopathy: A Systematic Review of Reported Clinical Cases

Presenter: Harris Majeed

October 26, 2025

Presentation TCT 2025

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Presenter: Puneet Aggarwal

October 25, 2025

Presentation TCT 2025

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Presenter: Toby Rogers

October 25, 2025

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2024

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

Presenter: Kylie Duckworth

October 27, 2024

Presentation TCT 2024

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

Presenter: Himaja Dutt Chigurupati

October 27, 2024

Presentation TCT 2024

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

Presenter: Nikhil Rao

October 27, 2024

Presentation TCT 2024

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

Presenter: Stanislav Fanta

October 27, 2024

Presentation TCT 2023

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

Presenter: Ndausung Udongwo

October 26, 2023

Presentation TCT 2023

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

Presenter: Said hajouli

October 26, 2023

Presentation TCT 2023

TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method

Presenter: Dena Hayes

October 26, 2023

Presentation TCT 2023

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

Presenter: Michael Bashline

October 26, 2023

Advertisement

TCT 566: Prognostic Significance of Coronary Microvascular Dysfunction for Long-term Adverse Outcomes in Hypertrophic Cardiomyopathy Patients

TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 563: Comparative Outcomes of Mavacamten with AV Nodal Blockers vs. AV Nodal Blockers Alone in Patients with Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

TCT 568: Safety and Long-Term Efficacy of First Septal Coil Embolization in Patients with Hypertrophic Obstructive Cardiomyopathy

TCT 1270: Impact of Frailty on Patients Undergoing TEER MitraClip With Underlying Hypertrophic Cardiomyopathy

TCT 562: Prognostic and Procedural Impact of Coexistent Aortic Stenosis in Hypertrophic Cardiomyopathy: A Propensity-Matched Cohort Study

TCT 559: TRANScatheter edge to edge rePAir for systolic anterior motion related mitral REgurgitation in patieNTs with hypertrophic cardiomyopathy. The TRANSPARENT international registry.

TCT 556: Fibromuscular Subaortic Stenosis Misdiagnosed as Dynamic Left Ventricular Outflow Obstruction due to Hypertrophic Cardiomyopathy: A Systematic Review of Reported Clinical Cases

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 479: Incomplete Resolution of Left Ventricular Outflow Tract Gradient After Alcohol Septal Ablation Is Predictive of Need for Reintervention in Hypertrophic Obstructive Cardiomyopathy: A Retrospective Cohort Study

TCT 478: Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: A 5-Year National Experience

TCT 477: Procedural Outcomes in 25 Years of Alcohol Septal Ablations at a Tertiary Level Medical Center

TCT 475: Long-Term Outcomes of Simultaneous Interventional Treatment for Hypertrophic Obstructive Cardiomyopathy and Concomitant Coronary Artery Disease

TCT 528: Procedural Complications and Outcomes in Patients with Hypertrophic Obstructive Cardiomyopathy Undergoing Septal Myomectomy Versus Alcohol Septal Ablation.

TCT 491: Diabetes mellitus as an independent risk for death and stroke in hypertrophic cardiomyopathy

TCT 437: Transbrachial Right Ventricular Endomyocardial Biopsy – A Patient-Preferred Method

TCT 421: Permanent Pacemaker Following Alcohol Septal Ablation – Prevalence of Utilization at 1 Year?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content